Trials / Recruiting
RecruitingNCT07367568
Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy
Comparison of Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy: A Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.
Detailed description
Postoperative pain following modified radical mastectomy (MRM) is a considerable consequence, impacting the ipsilateral upper limbs, axillae, and thorax, resulting in diminished functional ability and substantial economic and societal repercussions. Erector spinae plane block (ESPB), an interfascial block, minimizes nerve and vessel injury by allowing local anesthetics to diffuse across relevant spaces; it is technically simpler and has shown benefits in reducing postoperative analgesic use and pain scores. A novel technique, the costotransverse foramen block (CTFB), is one type of Inter-transverse process (ITP) blocks. This technique entails the anterior dispersion of the local anesthetic injectate into the paravertebral region, affecting the thoracic nerve at the injection site and neighboring levels, while exhibiting negligible posterior diffusion of dye to the deep back muscles
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Costotransverse foramen block | Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%. |
| OTHER | Erector spinae plane block | Patients will receive an ipsilateral ultrasound-guided erector spinae plane block with injection of 20 ml bupivacaine 0.25%. |
Timeline
- Start date
- 2026-01-24
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2026-01-26
- Last updated
- 2026-01-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07367568. Inclusion in this directory is not an endorsement.